Johnson & Johnson’s (J&J) stock fell 0.4% in premarket trade on Tuesday as investors positioned ahead of the healthcare giant ...

Johnson & Johnson said Tuesday it will spin off its orthopedics business into a new company called DePuy Synthes.

Protagonist Therapeutics eyes a Johnson & Johnson buyout interest, with blockbuster drug potential and high acquisition hopes ...

Reporting third quarter earnings on Tuesday, Johnson & Johnson CEO Joaquin Duato said the healthcare giant has not yet ...

Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company within the next 18 ...

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.

President Trump said he'd impose a 100% tariff on branded or patented drugs unless the drugmaker builds a manufacturing ...

Provider directories for Medicare Advantage and AI prior authorization in select states are among the changes for 2026.